Andrzej Niemierko
#146,301
Most Influential Person Now
Andrzej Niemierko's AcademicInfluence.com Rankings
Download Badge
Physics
Why Is Andrzej Niemierko Influential?
(Suggest an Edit or Addition)Andrzej Niemierko's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Relative biological effectiveness (RBE) values for proton beam therapy. (2002) (1170)
- Reporting and analyzing dose distributions: a concept of equivalent uniform dose. (1997) (1103)
- Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. (2008) (781)
- Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. (2002) (410)
- Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. (2011) (399)
- Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. (2012) (375)
- Modeling of normal tissue response to radiation: the critical volume model. (1993) (302)
- Radiation dose-response of human tumors. (1995) (298)
- A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. (2007) (268)
- Secondary Carcinogenesis in Patients Treated with Radiation: A Review of Data on Radiation-Induced Cancers in Human, Non-human Primate, Canine and Rodent Subjects (2007) (244)
- Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. (1991) (238)
- The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. (2012) (232)
- Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. (2010) (230)
- Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. (2017) (201)
- Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. (1993) (190)
- Second Tumors after Radiosurgery: Tip of the Iceberg or a Bump in the Road? (2003) (187)
- Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. (2001) (177)
- Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. (1999) (170)
- Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence. (2015) (160)
- Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. (2019) (151)
- Radiotherapy and breast reconstruction: complications and cosmesis with TRAM versus tissue expander/implant. (2002) (139)
- Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. (2008) (134)
- Proton Beams to Replace Photon Beams in Radical Dose Treatments (2003) (133)
- Optimization of 3D radiation therapy with both physical and biological end points and constraints. (1992) (132)
- Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma (2011) (130)
- Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential. (2013) (121)
- Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. (2002) (121)
- From physical dose constraints to equivalent uniform dose constraints in inverse radiotherapy planning. (2003) (118)
- Analysis of Data Errors in Clinical Research Databases (2008) (116)
- Permanent alopecia after cranial irradiation: dose-response relationship. (2004) (114)
- Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. (2012) (112)
- Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer. (2015) (112)
- Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain. (2020) (95)
- Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype (2012) (95)
- Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution. (1996) (93)
- Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. (2015) (92)
- Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. (2010) (86)
- Random sampling for evaluating treatment plans. (1990) (86)
- Delayed diagnosis in children with intracranial germ cell tumors. (2013) (86)
- Outcomes of proton therapy for patients with functional pituitary adenomas. (2014) (85)
- Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? (2013) (84)
- 2K09 and thereafter : the coming era of integrative bioinformatics, systems biology and intelligent computing for functional genomics and personalized medicine research (2010) (79)
- Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer. (2017) (77)
- Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. (2016) (76)
- Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms. (2012) (76)
- Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors. (2018) (75)
- Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. (2006) (74)
- Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases. (2015) (73)
- Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer. (2009) (73)
- Spinal cord dose tolerance to stereotactic body radiotherapy. (2019) (72)
- Identification of genes and pathways involved in kidney renal clear cell carcinoma (2014) (71)
- Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning. (2011) (70)
- Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses. (2014) (70)
- Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy (2016) (69)
- Pattern of Failure Analysis in Metastatic EGFR-Mutant Lung Cancer Treated with Tyrosine Kinase Inhibitors to Identify Candidates for Consolidation Stereotactic Body Radiation Therapy (2015) (68)
- Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy (2017) (68)
- Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy. (2017) (68)
- Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy. (2009) (67)
- Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. (2010) (66)
- Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features (2018) (66)
- Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. (2002) (65)
- Outcomes after whole brain reirradiation in patients with brain metastases. (2010) (64)
- Long‐term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer (2012) (63)
- Generalization of a model of tissue response to radiation based on the idea of functional subunits and binomial statistics. (2001) (63)
- Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy. (2017) (58)
- Proton stereotactic radiosurgery for the treatment of benign meningiomas. (2011) (58)
- Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis. (2002) (58)
- A Comparison of Critical Structure Dose and Toxicity Risks in Patients with Low Grade Gliomas Treated with IMRT versus Proton Radiation Therapy (2009) (56)
- Random search algorithm (RONSC) for optimization of radiation therapy with both physical and biological end points and constraints. (1992) (55)
- Deep inspiration breath-hold technique in left-sided breast cancer radiation therapy: Evaluating cardiac contact distance as a predictor of cardiac exposure for patient selection. (2015) (55)
- Survivin is a potential mediator of prostate cancer metastasis. (2010) (51)
- Cauda equina tolerance to high-dose fractionated irradiation. (2006) (50)
- Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma. (2012) (49)
- Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy. (2009) (48)
- Cording following treatment for breast cancer (2013) (46)
- Impact of genomic methylation on radiation sensitivity of colorectal carcinoma. (2010) (46)
- Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. (2012) (46)
- DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer. (2010) (42)
- A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. (2014) (42)
- Single Stage Direct-to-Implant Breast Reconstruction has less Complication Rates Than Tissue Expander/Implant and Comparable Rates to Autologous Reconstruction in Patients Receiving Postmastectomy Radiation. (2019) (41)
- Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy (2013) (40)
- Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. (1998) (40)
- FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR+) Breast Cancer (2019) (40)
- Single-fraction proton beam stereotactic radiosurgery for cerebral arteriovenous malformations. (2014) (38)
- Comparison of tissue genotyping (TG) vs circulating tumor DNA (ctDNA) for selection of matched therapy and impact on clinical outcomes among patients with metastatic breast cancer (MBC). (2018) (38)
- The influence of the size of the grid used for dose calculation on the accuracy of dose estimation. (1989) (38)
- Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors (2018) (37)
- Dose-volume effects in the spinal cord. (1994) (37)
- Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer. (2015) (36)
- Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. (2017) (35)
- Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer (2018) (34)
- Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer. (2012) (34)
- The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity (2018) (34)
- Planned two-fraction proton beam stereotactic radiosurgery for high-risk inoperable cerebral arteriovenous malformations. (2012) (34)
- Dose-volume distributions: a new approach to dose-volume histograms in three-dimensional treatment planning. (1994) (33)
- Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma. (2012) (33)
- Long-term outcomes of patients with spinal cord gliomas treated by modern conformal radiation techniques. (2011) (32)
- Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients. (2017) (32)
- Response to “Comment on ‘Reporting and analyzing dose distributions:\sA concept of equivalent uniform dose’ ” [Med Phys. 24, 1323–1324 (1997)] (1997) (31)
- Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies (2021) (31)
- Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer. (2013) (30)
- Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide (2018) (30)
- Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk. (2012) (30)
- Clinical Impact of Tumor Mutational Burden in Neuroblastoma. (2018) (30)
- Long‐term quality of life after definitive treatment for prostate cancer: patient‐reported outcomes in the second posttreatment decade (2017) (28)
- A single‐nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy (2012) (28)
- Long-term impact of a faculty mentoring program in academic medicine (2018) (28)
- Can axillary dissection be avoided in patients with sentinel lymph node metastasis? (2006) (28)
- Radiation Therapy Outcomes Models in the Era of Radiomics and Radiogenomics: Uncertainties and Validation. (2018) (28)
- Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients. (2016) (27)
- Brain necrosis in adult patients after proton therapy: Is there evidence for dependency on linear energy transfer (LET)? (2020) (27)
- The emerging genomics and systems biology research lead to systems genomics studies (2014) (26)
- Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience. (2021) (26)
- Outcome Following Local‐Regional Recurrence in Women with Early‐Stage Breast Cancer: Impact of Biologic Subtype (2015) (26)
- Towards the development of an error checker for radiotherapy treatment plans: a preliminary study (2007) (26)
- Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis (2009) (26)
- A multicenter analysis of abemaciclib after progression on palbociclib in patients (pts) with hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC). (2019) (25)
- Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy. (2012) (25)
- Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation. (2015) (24)
- Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model. (2019) (23)
- Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer? (2005) (22)
- Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients. (2006) (21)
- The use of variable grid spacing to accelerate dose calculations. (1989) (20)
- Adjuvant radiotherapy versus surveillance following surgical resection of atypical meningiomas. (2020) (19)
- Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: implications for radiation treatment planning. (2007) (19)
- Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience. (2017) (19)
- Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer (2019) (18)
- Risk stratification by somatic mutation burden in Ewing sarcoma (2019) (18)
- Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy. (2019) (18)
- Pretreatment growth rate predicts radiation response in vestibular schwannomas. (2014) (17)
- Modelling the dose-volume response of the spinal cord, based on the idea of damage to contiguous functional subunits. (2001) (17)
- Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with Trastuzumab-based chemotherapy (2017) (17)
- Improved local control with an aggressive strategy of preoperative (with or without intraoperative) radiation therapy combined with radical surgical resection for retroperitoneal sarcoma (2017) (17)
- Differences in lung injury after IMRT or proton therapy assessed by 18FDG PET imaging. (2018) (16)
- Modern Bridge Bearings and Expansion Joints for Road Bridges (2016) (16)
- Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient Setting. (2020) (15)
- The role of medical physicists and the AAPM in the development of treatment planning and optimization. (2008) (15)
- Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy. (2015) (15)
- Post‐operative renal function following nephrectomy as part of en bloc resection of retroperitoneal sarcoma (RPS) (2015) (15)
- Modeling Intracranial Second Tumor Risk and Estimates of Clinical Toxicity with Various Radiation Therapy Techniques for Patients with Pituitary Adenoma (2011) (14)
- Comments on "Sampling techniques for the evaluation of treatment plans" [Med. Phys. 20, 151-161 (1993)]. (1993) (14)
- Models of care and NCCN guideline adherence in very-low-risk prostate cancer. (2013) (14)
- Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcoma. (2011) (14)
- The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity (2017) (14)
- Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation. (2017) (13)
- Outcomes of proton therapy for the treatment of uveal metastases. (2013) (13)
- Radiation Treatments May Contribute to the Development of Cardiac Dysfunction in Breast Cancer Patients Treated with Chemotherapy and Trastuzumab (2008) (13)
- Radiobiological Models of Tissue Response to Radiation in Treatment Planning Systems (1998) (13)
- Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer (2018) (13)
- Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions. (2013) (13)
- Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy. (2019) (12)
- The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy (2014) (12)
- A Weighty Problem: Identification, Characteristics and Risk Factors for Errors in EMR Data. (2010) (12)
- Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma. (2007) (12)
- Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy (2020) (11)
- Potential of 18F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer (2013) (10)
- Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer (2018) (10)
- Inter- and Intramouse Heterogeneity of Radiation Response for a Growing Paired Organ (2008) (10)
- Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary? (2013) (10)
- Outcomes of Selective Bladder Preservation in the Elderly Treated With Conservative Surgery and Chemoradiation (2013) (10)
- Diversity Trends by Sex and Underrepresented in Medicine Status Among US Radiation and Medical Oncology Faculty Over 5 Decades. (2021) (10)
- From genes to networks: in systematic points of view (2011) (10)
- A clinical study of MLC-based IMRT lung dose calculation accuracy on plan evaluation parameters (2010) (10)
- Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer (2020) (9)
- Does lymphovascular invasion predict regional nodal failure in breast cancer patients with zero to three positive lymph nodes treated with conserving surgery and radiotherapy? Implications for regional radiation. (2010) (9)
- Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomas (2016) (9)
- Modelling tumor control probability (1992) (9)
- Effect of incomplete repair on normal tissue complication probability in the spinal cord. (2000) (9)
- Analyzing adjuvant radiotherapy suggests a non monotonic radio-sensitivity over tumor volumes (2008) (8)
- Promoting inter/multidisciplinary education and research in bioinformatics, systems biology and intelligent computing (2009) (8)
- Survival patterns following brain metastases for patients with melanoma in the MAP-kinase inhibitor era (2015) (8)
- Thoracolumbar spinal cord tolerance to high dose conformal proton-photon radiation therapy. (2016) (8)
- "Summary Page": a novel tool that reduces omitted data in research databases (2010) (8)
- Quality assurance and validation of individual IMRT treatment plans before delivery. (2004) (8)
- Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer (2020) (8)
- Racial and ethnic disparities among participants in precision oncology clinical studies. (2021) (7)
- Proton therapy for head and neck paragangliomas: A single institutional experience (2019) (7)
- Hypopituitarism After Cranial Irradiation for Meningiomas: A Single-Institution Experience. (2019) (7)
- Abstract PD1-13: Somatic BRCA mutation detection by circulating tumor DNA analysis in patients with metastatic breast cancer: Incidence and association with tumor genotyping results, germline BRCA mutation status, and clinical outcomes (2018) (7)
- Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer (2021) (7)
- The potential for proton therapy to improve clinical outcomes: Comparisons of proton and x-ray treatment plans for the purpose of tumor dose escalation and/or reduction of treatment-related morbidity (2000) (7)
- Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long‐term Results of a Single‐institution Experience (2017) (6)
- Multi-institutional matched comparison of radical cystectomy to trimodality therapy for muscle-invasive bladder cancer. (2022) (6)
- Predicting Tumor Malignancies using Combined Computational Intelligence, Bioinformatics and Laboratory Molecular Biology Approaches (2007) (6)
- Medical oncology consultation and minimization of overtreatment in men with low-risk prostate cancer. (2014) (6)
- Validation of a Web-based Predictive Nomogram for Ipsilateral Breast Tumor Recurrence after Breast Conserving Therapy (2008) (6)
- Proton Therapy for Mediastinal Lymphomas: An 8-year Single-institution Report (2015) (6)
- A Model for Optimizing Normal Tissue Complication Probability in the Spinal Cord Using a Generalized Incomplete Repair Scheme (2001) (6)
- Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose? (2017) (6)
- Biological target volume (BTV) determined with dose response data from the correlation between metabolic rate of glucose (MRG) measured with 18F-FDG PET and pathologic complete response (PCR) in stage III non-small cell lung cancer (NSCLC) (2000) (5)
- Computer optimization of 3D radiation therapy treatment plans with biological models of tissue response (1990) (5)
- FGFR gene amplification and response to endocrine therapy in metastatic hormone receptor positive (HR+) breast cancer. (2017) (5)
- Target dose inhomogeneity and the location of recurrence (2002) (5)
- Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection (2021) (5)
- Advances in translational bioinformatics facilitate revealing the landscape of complex disease mechanisms (2014) (5)
- Post-operative radiation therapy to the surgical cavity with standard fractionation in patients with brain metastases (2020) (5)
- Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes (2013) (4)
- Modelling of normal tissue response (1991) (4)
- The importance of dose-volume histogram analysis in design and evaluation of dose escalation studies (1994) (4)
- Outcome and Toxicity of Proton Therapy for Vestibular Schwannoma: A Cohort Study (2021) (4)
- Tumor genomics and response to CDK 4/6 inhibitors for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC). (2017) (4)
- Benign Meningiomas With Atypical Features: Correlation of Histopathological Features With Clinical Outcomes (2013) (4)
- Role of FLT PET in Supplementing FDG PET for Robust Classification of Metabolic Response Even in the Presence of Coexisting Pneumonitis in Radiotherapy or Chemoradiotherapy for Lung Cancer (2011) (4)
- Dose-Volume Characteristics of Brain Lobe Late Response Following Proton-Photon Radiotherapy of Paranasal Sinus Cancer (2005) (4)
- Is a higher boost dose of radiation necessary after breast-conserving therapy for patients with breast cancer with final close or positive margins? (2015) (4)
- Treatment of Unresectable Osteosarcoma with Proton Therapy (2009) (4)
- Clinical needs assessment for sexual health among cancer patients receiving pelvic radiation: Implications for development of a radiation oncology sexual health clinic. (2017) (3)
- Pilot of Respiratory Gated Proton Beam Therapy for Liver Tumors (2009) (3)
- Immune-related adverse events (IRAEs) in metastatic lung cancer patients receiving PD-1/PD-L1 inhibitors and thoracic radiotherapy. (2017) (3)
- Single Fraction Proton Beam Stereotactic Radiosurgery (PSRS) for Inoperable Cerebral Arteriovenous Malformations (AVMs) (2012) (3)
- Atypical histopathological features and the risk of treatment failure in non-malignant meningiomas: a multi-institutional analysis. (2019) (3)
- Long-term Outcomes After Bladder-Preserving Combined Modality Therapy for Patients With Muscle-Invasive Bladder Cancer (2015) (3)
- Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer–Specific Mortality (2022) (3)
- Quantification of Mediastinal Lymph Node Movement Using 4D CT Scan: Implications for Radiation Treatment Planning (2005) (3)
- Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases (2020) (3)
- Prediction of overall pulmonary function loss in relation to the 3D dose distribution for patients with breast cancer and malignant lymphoma. (1999) (3)
- Patterns of Failure Following Proton Therapy in Medulloblastoma: LET Distributions and RBE Associations for Relapses (2014) (3)
- The Interaction of Waiting Time and Patient Experience during Radiation Therapy: A Survey of Patients from a Tertiary Cancer Center. (2019) (3)
- Brain Necrosis in Adult Proton Therapy Patients. Do Necrotic Regions Have Elevated Linear Energy Transfer? (2019) (3)
- Long-term Outcomes of Neoadjuvant Chemotherapy (NC) before Chemoradiation (CRT) for Locally Advanced Pancreatic Cancer (LAPC) (2011) (2)
- Clinical Needs Assessment for Sexual Health Among Cancer Patients Receiving Pelvic Radiation (2016) (2)
- Abstract 2638: Sacituzumab Govitecan, combination with PARP inhibitor, Talazoparib, in metastatic triple-negative breast cancer (TNBC): Translational investigation (2022) (2)
- Second Tumor Risk and Projected Late Effects after Proton vs. Intensity Modulated Photon Radiotherapy for Benign Meningioma: A Dosimetric Comparison (2010) (2)
- The use of Anti-PD1 Therapy in Melanoma Patients with Known Brain Metastases: Survival, Durable Intracranial Progression Free Survival and Radionecrosis (2018) (2)
- Dosimetric Comparison of Proton Versus Photon Radiosurgery for Treatment of Pituitary Adenoma (2021) (2)
- Deep Inspiration Breath-Hold Technique in Left-Sided Breast Cancer Radiation Therapy: Evaluating Cardiac Contact Distance as a Predictor of Cardiac Exposure (2013) (2)
- Outcomes for a multi-institutional cohort of patients treated with intra-operative radiation therapy for advanced or recurrent renal cell carcinoma. (2013) (2)
- Age, Breast Cancer (BC) Subtype, Approximation, and Local Recurrence (LR) after Breast-Conserving Therapy (BCT) (2011) (2)
- Margin Status and the Risk of Local Recurrence (LR) in Patients With Early-Stage Breast Cancer Treated With Breast-Conserving Therapy (BCT) (2013) (2)
- Outcomes and Tolerability of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer in Elderly Patients (2017) (2)
- Patterns of Failure and Risk Factors for Recurrence Among Low-Grade Glioma Patients Treated With Proton Radiation Therapy (2017) (2)
- Liver Metastasis–Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients (2021) (2)
- Percolation-based cluster models of dose-volume effects (2004) (2)
- Early salvage versus adjuvant post-prostatectomy radiation therapy: Long-term results of a large institutional experience. (2016) (2)
- Abstract P1-13-03: Association of PIK3CA mutation with clinical response to specific endocrine therapies in metastatic hormone receptor positive (HR+) breast cancer (2015) (2)
- Equivalent uniform dose predicts delayed hyperintensity on T1-weighted magnetic resonance imaging after combined proton and photon irradiation in paranasal sinus cancer (2004) (2)
- 13 Skull base chordomas: Analysis of dose-response characteristics☆ (1997) (2)
- Proton Radiation Therapy for Head and Neck Paragangliomas: A Single Institution Experience (2017) (2)
- Survival patterns following brain metastases for patients with melanoma in the targeted therapy era. (2013) (2)
- SU-E-T-552: Maximizing the Biological Effect of Proton Dose Delivered with Scanned Beam. (2012) (1)
- Postoperative Radiation Therapy Utilization for Localized Breast Cancer in Botswana (2017) (1)
- Fifteen-year Outcomes of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer: The Long-term MGH Experience (2009) (1)
- Abstract P2-02-18: Higher mutation burden and mutant allele fraction of circulating tumor DNA corresponds to worse progression free survival in metastatic breast cancer patients (2018) (1)
- Assessment of the Utility of Laparoscopy and Peritoneal Cytology in the Staging of Pancreatic Cancer (2017) (1)
- The role of proton beam therapy in central neurocytoma: A single-institution experience. (2018) (1)
- Cost-Effectiveness Analysis of Early Salvage Radiation Therapy Versus Adjuvant Radiation Therapy After Radical Prostatectomy (2016) (1)
- Proton Radiotherapy For Vestibular Schwannomas: A Cohort Study (2020) (1)
- Abstract P4-12-04: Breast cancer subtype, age and lymph node status as predictors of local recurrence following breast-conserving therapy (2017) (1)
- Clinical outcomes of patients with stage IV cancer receiving immune checkpoint inhibitors in the inpatient setting. (2019) (1)
- MP26-12 INCIDENCE AND MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCES AFTER COMPLETE RESPONSE TO COMBINED-MODALITY ORGAN-PRESERVING THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER (2015) (1)
- Rubber Bridge Bearings Test Results After 30 Years in Service (1996) (1)
- Abstract PD13-07: PD13-07 Combination therapy with the AKT inhibitor, ipatasertib, endocrine therapy, and a CDK4/6 inhibitor for hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC): results from the phase I TAKTIC trial (2023) (1)
- Proton FLASH effects on mouse skin at different oxygen tensions (2023) (1)
- Multidisciplinary care and management of very low-risk prostate cancer. (2013) (1)
- Use of Involuntary Emergency Treatment by Physicians and Law Enforcement for Persons With High-Risk Drug Use or Alcohol Dependence (2021) (1)
- Incidence and Predictors of Thyroid Dysfunction following Three-Dimensional Conformal Radiation Therapy (3D-CRT) to Low Neck as Component of Adjuvant Radiation in Women with Breast Cancer: Prospective Long Term Follow-Up (2009) (1)
- Michael Goitein, 1939-2016: A Giant of Modern Medical Physics. (2017) (1)
- 4D CT Planning Improves Tumor Control Probability (TCP) When Compared with Helical CT Scan in 3D Conformal Radiation Therapy (CRT) in Lung Cancer (2005) (1)
- Identification of genes and pathways involved in kidney renal clear cell carcinoma (2014) (1)
- Reduction in Wound Complications With Low- Versus High-Dose Preoperative Radiation Therapy for Sacro-Coccygeal Chordomas (2013) (1)
- Effect of Mismatch Repair Status on Outcome of Early Stage Grade 1-2 Endometrial Cancer Treated With Vaginal Brachytherapy (2020) (1)
- Radiomodifying responses of vitamin E and epigallocatechin gallate supplementation during irradiation of implanted tumors. (2004) (1)
- Patterns of care and outcomes of definitive external beam radiotherapy and radioembolization for localized hepatocellular carcinoma: A propensity score-adjusted analysis. (2019) (1)
- Abstract PD2-03: Association between co-existing genomic alterations and abemaciclib benefit in patients with metastatic hormone receptor-positive breast cancer with ESR1 mutations following disease progression on prior endocrine therapy plus palbociclib or ribociclib (2022) (1)
- Effect of Mismatch Repair Status on Outcome of Early-Stage Grade 1 to 2 Endometrial Cancer Treated With Vaginal Brachytherapy (2021) (1)
- Pancreatic Neuroendocrine Tumors With Involved Surgical Margins: Prognostic Factors and the Role of Adjuvant (2012) (1)
- The Impact of Data Entry Errors on the Findings in Radiation Oncology Research (2005) (1)
- Data Entry Errors in Clinical Research Databases (2007) (1)
- Second Tumor Risk With Modern Radiotherapy for Pituitary Adenomas (2007) (1)
- Adjuvant radiation therapy for early-stage seminoma: Proton-photon comparison and second cancer risk. (2011) (1)
- Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy. (2011) (1)
- Advances in translational bioinformatics facilitate revealing the landscape of complex disease mechanisms (2014) (1)
- Comparison of the cell-free DNA genomics in patients with metastatic breast cancer (MBC) who develop brain metastases versus those without brain metastases. (2020) (1)
- Molecular alterations in the Ras-Raf-Erk (MAPK) pathway in metastatic hormone receptor positive (HR+)/HER2- breast cancer: Incidence and impact on clinical outcomes. (2018) (1)
- Breast Cancer Subtype Approximated by ER, PR, and Her2 Receptors Is Associated With Local-Regional and Distant Failure After Breast-Conserving Therapy (2007) (1)
- The emerging genomics and systems biology research lead to systems genomics studies (2014) (1)
- Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes (2013) (1)
- ORAL02.03: Robust Correlation Between Metabolic Response Measured with 18F‐FDG PET Soon After Therapy and Clinical Outcome in Lung Cancer: Topic: Radiation Oncology (2016) (0)
- Low Dose Versus High Dose Radiation Therapy for Indolent Primary Cutaneous B-Cell Lymphomas (2015) (0)
- Abstract PS17-02: Molecular alterations in the androgen receptor and associated clinical outcomes in hormone receptor-positive/HER2- metastatic breast cancer (2021) (0)
- Genomic landscape of primary breast cancer in black vs. white women and association with tumor recurrence. (2015) (0)
- 14: Women With 10 Years of Recurrence-Free Survival Following Lumpectomy and Radiation for Invasive Breast Cancer Continue to be at Risk for Subsequent Relapse (2006) (0)
- Breast Cancer Subtype, Lymph Node Involvement, and Age As Predictors of Isolated Local-Regional Recurrence Following Breast-Conserving Therapy (2016) (0)
- Histopathologic Prognostic Factors of Recurrence Following Surgery and Radiation Therapy for Atypical and Malignant Meningiomas (2016) (0)
- Long-term outcomes after bladder-preserving combined-modality therapy for patients with muscle-invasive bladder cancer. (2016) (0)
- Long-term Results of Early Salvage Versus Adjuvant Postprostatectomy Radiation: A Large Institutional Experience (2015) (0)
- Proton Radiosurgery for Management of Brain Metastases (2012) (0)
- Neoadjuvant IMRT with Chemotherapy for Esophageal Cancer Allows Cardiac Sparing Without Increasing Postoperative Pulmonary Complications (2015) (0)
- Improved Local Tumor Control With Supplementary Dose of Radiation Guided by 18F-FDG PET Soon After Standard Dose Radiation Therapy and Concurrent Chemotherapy in Inoperable Stages II and III Non-Small Cell Lung Cancer (2015) (0)
- Early Response Assessment After Hypofractionated Proton Radiation Therapy for Primary Liver Tumors (2015) (0)
- Non-Monotonic Radio-Sensitivity over Tumor Volumes on Adjuvant Radio Therapy A New Insight on Cell Killing and Modeling (2007) (0)
- Decision-making in Early Breast Cancer Patients with Positive Margins after Re-excision: Continue Re-excisions or Convert to Mastectomy? (2009) (0)
- Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-Adjusted Analysis (2019) (0)
- A Nomogram for Estimating the Risk of Lymphedema Following Treatment for Breast Cancer (2012) (0)
- Outcomes of Proton Radiation Therapy for Patients With Functional Pituitary Adenomas (2013) (0)
- Does Lymphovascular Invasion Predict Regional Nodal Failure in Stage I/II Breast Cancer Patients Treated with Conserving Surgery and Radiation Therapy? Implications for Regional Radiation (2009) (0)
- Abstract P1-10-14: Higher radiation dose to the heart in left sided breast cancer; anatomy versus dosimetry (2023) (0)
- Acute Quality of Life (QOL) Effects of Chemoradiation Therapy (CRT) for Locally-advanced Rectal Cancer (2007) (0)
- Impact of U.S. Preventative Services Task Force grade D recommendation against prostate-specific antigen screening on prostate cancer mortality. (2022) (0)
- ADJUVANT CHEMORADIATION PROVIDES BENEFIT FOR PATIENTS WITH ADVANCED INVASIVE INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM (2007) (0)
- FLT PET for rising FDG uptake suggestive of local recurrence after radiotherapy (RT) or chemo-radiotherapy (CT+RT) in lung cancer (2008) (0)
- NTOX-06. INCREASE OF PSEUDOPROGRESSION AND TREATMENT RELATED EFFECTS IN LOW-GRADE GLIOMA PATIENTS TREATED WITH PROTON RADIATION AND TEMOZOLOMIDE (2017) (0)
- Esophagitis Identified in Restaging FDG-PET after Radiotherapy or Chemo-radiotherapy in Lung Cancer (2008) (0)
- Inverse probability treatment weighting comparison of radical cystectomy to trimodality therapy for cT2-cT4 muscle invasive bladder cancer (2023) (0)
- Oral Scientific SessionsMulti-institutional Outcomes of Postprostatectomy Adjuvant Versus Early Salvage Radiation Therapy in Prostate Cancer Patients With Adverse Pathologic Features (2017) (0)
- Abstract P3-09-11: Clinical characteristics associated withBRCA1/2mutations identified on routine tumor tissue genotyping in metastatic breast cancer (2022) (0)
- [Dosimetry and treatment planning in Hodgkin's disease by mantle field radiotherapy]. (1982) (0)
- or Incompletely Resected Osteosarcoma (2011) (0)
- Effect of Mid-course Replanning CT on Tumor and Normal Structure Dosimetry and Projected Toxicities during Chemoradiotherapy for Small Cell Lung Cancer (2010) (0)
- Abstract P6-09-04: The Association of Low Level Arm Volume Increases with Lymphedema Symptoms Following Treatment for Breast Cancer (2012) (0)
- Thoracolumbar Spinal Cord Tolerance to High-Dose Conformal Proton-Photon Radiation Therapy (2015) (0)
- SU‐FF‐T‐361: Planning Study of Intensity‐Modulated and 3D Conformal Radiotherapy of Whole Pelvis Including Inguinal Lymphatics: Radiobiological Considerations for Designing New Fractionation Schemes (2006) (0)
- Abstract PS18-19: Comparison of metastatic genomic profile in patients ≤45 years and patients >45 years with triple-negative breast cancer (2021) (0)
- LET Guided Biological Optimization in IMPT: Implications on RBE Value (2012) (0)
- The Natural History of Nonmuscle-Invasive Bladder Cancer Recurrences After Complete Response to Combined-Modality Organ-Preserving Therapy for Muscle-Invasive Bladder Cancer (2016) (0)
- Physical and biological aspects of modern radiation therapy planning (2003) (0)
- Incidence of Pneumonitis in Metastatic Lung Cancer Patients Receiving Immune Checkpoint Inhibitors With or Without Thoracic Radiation Therapy (2017) (0)
- Abstract P4-08-08: Genomic progression, detected by circulating tumor DNA (ctDNA) sequencing, as an early predictor of disease progression in metastatic breast cancer (MBC) (2019) (0)
- Defining the Optimal Dose for 3D-Conformal Accelerated Partial Breast Irradiation (APBI): 10-years Follow Up of a Dose-Escalation Trial (2020) (0)
- Post-operative radiation therapy to the surgical cavity with standard fractionation in patients with brain metastases (2020) (0)
- Abstract PD1-10: Impact of Race on Clinical, Socioeconomic, and Genomic Characteristics, Clinical Trial Participation, and Receipt of Genotype-matched Therapy Among Patients with Metastatic Breast Cancer (2023) (0)
- Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer (2023) (0)
- WE-A-201-02: Modern Statistical Modeling. (2016) (0)
- Abstract P4-01-06: Comparison of tumor genotyping and cell-free circulating tumor DNA sequencing in metastatic breast cancer patients and their utility in the selection of matched therapy (2019) (0)
- Prediction of Response in Radiation Therapy: Part 1—The Physical and Biological Basis; Part 2—Analytical Models and Modelling, edited Bhudatt R. Paliwal, John F. Fowler, Donald E. Herbert, Timothy J. Kinsella, and Colin G. Orton (1990) (0)
- Propensity matched comparison of radical cystectomy with trimodality therapy for muscle invasive bladder cancer (MIBC): A multi-institutional study (2022) (0)
- Clinical Outcomes of Combined Modality Bladder-Sparing Therapy for Patients With Histologic Variants of Bladder Cancer (2016) (0)
- Abstract P5-14-09: Comparison of cell-free DNA genomics of breast cancer associated-chest wall disease vs. age & subtype matched controls with metastatic breast cancer not involving the chest wall (2023) (0)
- Biological Aspects of IMRT Planning and Delivery (2006) (0)
- Effects of Proton Craniospinal Radiation on Vertebral Body Growth Retardation in Children. (2022) (0)
- RONC-20. VERTEBRAL BODY GROWTH RETARDATION FOLLOWING PROTON CRANIOSPINAL RADIATION (2018) (0)
- Timing of Adjuvant Radiotherapy in Atypical Meningiomas (2020) (0)
- Concept of biologically normalized dose-volume histograms for 3D radiation treatment planning (1996) (0)
- MP49-17 CLINICAL OUTCOMES OF PATIENTS WITH HISTOLOGIC VARIANTS OF BLADDER CANCER TREATED WITH TRIMODAL BLADDER-SPARING THERAPY (2016) (0)
- E16. 4D CT (Computed Tomography) improves TCP without an increase in NTCP of lung when compared with helical CT planning in 3D conformal radiation therapy (CRT) for patients with lung cancer (2005) (0)
- Metabolic Response of Lung Cancer Measured With 18F-FDG PET at Sequential Intervals After Radiochemotherapy (RT + CT) and Its Predictive Power for Tumor Control: Primary Tumor Versus Involved Regional Lymph Node (2014) (0)
- Exploring big-data analysis using integrative systems biology approaches for kidney renal clear cell carcinoma studies (2014) (0)
- 184Biological modelling in treatment planning (1996) (0)
- Stereotactic Radiation Treatment in Recurrent High-grade Glioma (2011) (0)
- IMPROVED OUTCOME OF PANCREATIC ADENOCARCINOMA ARISING IN INTRADUCTAL PAPILLARY MUCINOUS TUMORS IS DUE TO EARLIER STAGE AT PRESENTATION (2007) (0)
- FDG uptake at sequential intervals after radiotherapy (RT) or RT of chemo-radiotherapy (CT+RT) and its predictive value for clinical outcome of primary lung cancer (2007) (0)
- Long term neurological sequelae of high dose 3D conformal fractionated combined proton-photon therapy to the cauda equina (2004) (0)
- PD09-03 INVERSE PROBABILITY TREATMENT WEIGHTING COMPARISON OF RADICAL CYSTECTOMY TO TRIMODALITY THERAPY FOR CT2-CT4 MUSCLE INVASIVE BLADDER CANCER (2023) (0)
- Radiation Safety for Pregnant Workers at a Proton Facility. (2017) (0)
- Outcome Following Local-Regional Recurrence (LRR) in Women With Early-Stage Breast Cancer: Impact of Biologic Subtype (2014) (0)
- Identification of genes and pathways involved in kidney renal clear cell carcinoma DEG dataset (2014) (0)
- Brain Metastases After Breast-conserving Therapy for Early-stage Breast Cancer: Incidence and Characteristics by Subtype (2012) (0)
- Tolerability and effectiveness of pertuzumab-containing neoadjuvant (NA) regimens vs. AC-TH for HER2-positive (+) localized breast cancer (BC). (2016) (0)
- Renal function in bladder cancer patients after trimodality therapy: Long-term results of a large institutional experience. (2016) (0)
- Scientific Review: A new insight on predicting tumour malignancies using synergistic computational intelligence and bioinformatics approaches (2009) (0)
- Clinical and genomic factors associated with outcome following ablative radiotherapy for oligometastatic and oligoprogressive liver tumors. (2020) (0)
- Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-Term Results of a Large Institutional Experience (2016) (0)
- Optimal Reconstruction Type and PMRT Timing for Breast Cancer Patients treated by Neoadjuvant Chemotherapy and Mastectomy. (2019) (0)
- Demographic trends among ASTRO clinical practice guideline task force participants from 2010-2022. (2022) (0)
- PD42-01 PROPENSITY MATCHED COMPARISON OF RADICAL CYSTECTOMY WITH TRIMODALITY THERAPY FOR MUSCLE INVASIVE BLADDER CANCER (MIBC): A MULTI-INSTITUTIONAL STUDY (2022) (0)
- Outcomes of Patients with Benign Meningiomas Treated with Proton Stereotactic Radiosurgery (2008) (0)
- Outcome of Patients With Breast Cancer Treated With Breast Conserving Treatment or Mastectomy and No Postmastectomy Radiation and With Isolated Tumor Cells (2013) (0)
- Nomogram for Predicting Risk of Cystectomy or Recurrence after Bladder Preserving Trimodality Therapy for Muscle Invasive Bladder Cancer (2011) (0)
- Comparing Adjuvant vs Early-Salvage Radiotherapy After Radical Prostatectomy-Reply. (2018) (0)
- TU‐D‐J‐6C‐05: Investigation of the Actually Delivered Patient Dose in Lung IMRT Treatment Based On Deformable Registration of 4D CT Data and Monte Carlo Simulations (2005) (0)
- Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma (2019) (0)
- Feasibility of Simultaneous Integrated Boost (SIB) to Gross Disease in Spine Radiosurgery (2016) (0)
- Irradiation of Anatomically Defined Pelvic Bone Marrow Subsites and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation (2016) (0)
- Implementation of a model for estimating normal tissue complication probability: D0erivation of model parameters from clinical data (1993) (0)
- Abstract 6744: Cell-free DNA detection of alterations in the MAPK pathway in metastatic hormone receptor positive breast cancer: A multi-institutional analysis of incidence and clinical outcomes (2023) (0)
- The Impact of Different Hypofractionated Stereotactic Radiation Therapy Regimens for Brain Metastases on Local Control and Toxicity (2013) (0)
- THE MEASUREMENT OF STRESS TENSOR COMPONENTS IN FINE SAND /IN POLISH/ (1968) (0)
- In Reply to Dr. Jenkins (2008) (0)
- Abstract PD17-03: Cell-free DNA monitoring in a phase II study of adjuvant endocrine therapy with CDK 4/6 inhibitor ribociclib for localized HR+/HER2- breast cancer (LEADER) (2023) (0)
- Dose response relationship between PET-FDG uptake after chemo-radiotherapy (CT + RT) and histopathologic tumor control probability (pTCP) in stage III non-small cell lung cancer (NSCLC) (2000) (0)
- Proton Radiation Therapy for Pediatric Chordomas of the Base of Skull (2020) (0)
- Impact of 4D CT Planning for Lung Cancer on Tumor Control Probability as a Function of the Extent of Tumor Motion With Respiration (2007) (0)
- Radiation Tolerance of the Optic Pathway After Fractionated Proton Radiation Therapy (2014) (0)
- Gallbladder Toxicity and High Dose Ablative Intent Radiation for Liver Tumors: Should We Constrain the Dose? (2015) (0)
- Radiation Esophagitis Graded With Common Terminology Criteria for Adverse Events (CTCAE) Revisited With 10 Days and 3 Months Posttherapy 18F-FDG Positron Emission Tomography in Lung Cancer (2016) (0)
- Association of pathologic complete response following neoadjuvant chemotherapy with survival among young women with breast cancer. (2012) (0)
- Long-Term Outcomes of Myeloablative Hematopoietic Cell Transplantation Using Total Body Irradiation Prior to Systemic Therapy (2012) (0)
- Outcomes and tolerability of selective bladder preservation by combined modality therapy for invasive bladder cancer in elderly patients. (2017) (0)
- Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: a contemporary single-institution experience. (2022) (0)
- FDG Uptake Quantified with FDG PET 10-12 Days after Radiotherapy or Chemoradiotherapy in Lung Cancer is Molecular-Biomarker Capable for Predicting Therapy Outcome and Identifying Patients in Need for Timely Salvage Therapy (2010) (0)
- SU‐E‐T‐659: Maximizing the Therapeutic Effect of a Fractionated Treatment with Delivery of Inhomogeneous Daily Dose Distributions (2011) (0)
- MP62-14 LONG-TERM RESULTS OF POST-PROSTATECTOMY RADIOTHERAPY: A LARGE INSTITUTIONAL EXPERIENCE (2015) (0)
- Pretreatment Tumor Size is Associated with Pathologic Complete Response to Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma (2011) (0)
- Understanding Anxiety in Patients Receiving Vaginal Brachytherapy for Endometrial Cancer (2022) (0)
- SU‐FF‐T‐107: Clinical Study to Evaluate the Dose Calculation Accuracy for IMRT Lung Patients (2007) (0)
- Does Omitting IMC Irradiation Reduce Cardiac Exposure for all Breast Cancer Patients Treated With Herceptin-Based Chemotherapy? (2007) (0)
- MO‐B‐211A‐02: Biological/Clinical Outcomes Models in Radiation Therapy Planning — (Equivalent Uniform Dose (EUD) and Tumor Control Probability (TCP)) (2009) (0)
- Consolidative Whole Abdomen Radiation Therapy After Surgery and Carboplatin-Taxol-based Chemotherapy for Advanced Epithelial Uterine Endometrial Malignancy: Feasibility and Clinical Outcomes (2012) (0)
- Does Lobular Carcinoma In Situ (LCIS) at the Surgical Margins Increase the Risk of Local Failure in Patients With Invasive Breast Cancer Receiving Conservative Treatment (2012) (0)
- Abstract P5-02-07: Cell-free DNA detection of GATA3 mutations in metastatic hormone receptor positive breast cancer: a retrospective, observational multi-institutional analysis (2023) (0)
- TH-C-213AB-11: LET-Guided Biological Optimization in IMPT (2012) (0)
- Two-fraction Proton Beam Stereotactic Radiosurgery For High-Risk Inoperable Cerebral Arteriovenous Malformations (AVMs) (2011) (0)
- U.S. radiation oncology and medical oncology department faculty diversity trends by sex and underrepresented in medicine status over five decades. (2021) (0)
- Optimal timing of post-prostatectomy radiotherapy for prostate cancer with high-risk pathologic features: A multi-institutional analysis. (2018) (0)
- Association of Dosimetric and Treatment Related Factors with Radiation Induced Lymphopenia and Overall Survival among Patients Treated in the FOLFIRINOX Era (2018) (0)
- Risk factors for disease progression after post-prostatectomy salvage radiation: Long-term results of a large institutional experience. (2016) (0)
- 2128 : Optimizing the Cardiac and Pulmonary Dose in Treatment Planning for Distal Esophageal Cancer: Does IMRT Always Produce the Best Plan? (2006) (0)
- Abstract P5-20-02: HER2 mutations detected by ctDNA in ER+/HER2- metastatic breast cancer patients: Incidence and impact on clinical outcomes (2018) (0)
- A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. (2023) (0)
- Improved Outcomes of Invasive Papillary Mucinous Tumors of the Pancreas, Different Biology or Different Stage? (2007) (0)
- 2099 : Adjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms of the Pancreas (2006) (0)
- The Role of Proton Radiation Therapy in Central Neurocytoma (2017) (0)
- FDG Uptake at Sequential Intervals After Radiotherapy (RT) or RT of Chemo-Radiotherapy (CT+RT) and its Predictive Value for Tumor Control Probability (TCP) of Metastatic Lung Cancer in Regional Lymph Nodes (2007) (0)
- Racial and ethnic disparities in a real-world precision oncology data registry (2023) (0)
- 2490: Treatment-Related Pneumonitis After Concurrent Cisplatin/Etoposide and Thoracic Radiation Therapy in Lung Cancer (2006) (0)
- Impact of the COVID-19 Pandemic on Prostate Cancer Radiotherapy Practice Patterns: A Northeast Regional Longitudinal Survey Study (2021) (0)
- Surgery and Proton Radiation Therapy for Pediatric Base of Skull Chordomas: Long-term Clinical Outcomes for 204 patients. (2023) (0)
- 2 K 09 and Thereafter : The Coming Era of Integrative Bioinformatics (2010) (0)
- The prognostic utility of hemoglobin and lymphocytopenia in bladder-sparing therapy. (2017) (0)
- IN REGARD TO SHER ET AL : QUANTIFICATION OF MEDIASTINAL AND HILAR LYMPH NODE MOVEMENT USING FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY SCAN: IMPLICATIONS FOR RADIATION TREATMENT PLANNING. Authors' reply (2008) (0)
- Abstract P4-09-06: Brain metastases (BM) in patients with metastatic breast cancer (MBC) and circulating cell-free DNA (cfDNA) somaticBRCAmutations (2020) (0)
- Dose sampling for dose-volume displays and for TCP/NTCP calculations (1995) (0)
- Abstract P1-14-02: Phase II study of adjuvant endocrine therapy with CDK 4/6 inhibitor, ribociclib, for localized ER+/HER2- breast cancer (LEADER, part 1) (2022) (0)
- Poster ViewingCNS Hemangiopericytoma/Solitary Fibrous Tumor: Late Local Recurrence and Distant Failures Continue to Increase With Time Following Definitive Management (2017) (0)
- Higher Boost Dose of Radiation Instead of Mastectomy for Patients With Final Positive/Close Margins After Breast-Conserving Therapy (2013) (0)
- Long-term QOL Outcome after Proton Radiation for Localized Prostate Cancer (2010) (0)
- Left Hippocampal Dosimetry Correlates With Visual and Verbal Memory Outcomes in Pediatric Brain Tumor Survivors (2017) (0)
- Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer: Significance of Mutations in EGFR, ALK, or KRAS on Radiation Therapy Response and Survival (2013) (0)
- Differences in Quality of Life Between Men and Women who Undergo Bladder Preservation with Trimodality Therapy (2021) (0)
- Academic Workforce Diversity Trends by Sex and Underrepresented in Medicine Status Among US Radiation Oncology & Medical Oncology Faculty Over Five Decades. (2021) (0)
- Robust Correlation between Immediate Post Radio-Chemotherapy FDG PET Response and Clinical Outcome and Impact of Salvage Radiation for Partial Metabolic Responders in Locally Advanced Non–Small Cell Lung Cancer (2017) (0)
- Elevated Proton Radiation Therapy Dose to Left Temporal Lobe or Whole-Brain Correlates With Decline in Full-Scale IQ Components for Pediatric CNS Tumor Survivors (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andrzej Niemierko?
Andrzej Niemierko is affiliated with the following schools:
